Posted by on Jul 31, 2019 in Prostate cancer | 0 comments

In a nutshell

This phase 3 trial will compare the safety and effectiveness of hypofractionated radiotherapy (HF-RT) to standard radiotherapy (RT). 

The main outcomes will be the number of grade 2 side effects and disease control. This trial is recruiting in Houston, Texas, United States. 

The details

Radiation therapy (RT) is a standard treatment for prostate cancer (PC). It can be very effective in killing cancer cells. It is also associated with some negative side effects. Standard RT uses a high energy beam to kill cancer cells. Hypofractionated radiation therapy (HF-RT) is a newer type of RT. It uses higher doses of energy over shorter periods of time. This may reduce the level of side effects. 

This trial will compare the safety and effectiveness of HF-RT to standard RT. The main outcome will be the number of grade 2 side effects and disease control.

Who are they looking for?

This trial will recruit 176 patients with PC that has been surgically removed. Patients can receive androgen deprivation therapy (ADT) up to 24 months before the trial.  

Patients cannot take part in the trial of they have had prior RT or chemotherapy. Patients cannot have medical conditions such as lupus, scleroderma, calcinosis, severe kidney or liver disease. Patients with unstable heart conditions e.g. angina, congestive heart failure are excluded from the trial. 

How will it work

Patients will be randomly assigned to standard RT or HF-RT. This will be performed after PC surgery. RT will last 6.5 weeks. HF-RT will last 4.5 weeks. Patients will return for follow-up assessment after 3-6 months, and every 6-12 months thereafter (maximum 5 years).

The main outcomes will be the number of grade 2 side effects to the digestive or urinary system and tumor control.

Clinical trial locations

Locations near 43201, United States (Change):
Please enter zip/postal code and country to help us offer locations near you
Show only recruiting locations
Type:Interventional
Participants:176
Study ID:NCT03987386
Want personalized notifications? Get notified only when trials are matching for you.
(it's free)